Home » Psychology news » Phase I clinical trial shows drug shrinks melanoma brain metastases
Phase I clinical trial shows drug shrinks melanoma brain metastases
May 18, 2012 by NewsBot
An experimental drug targeting a common mutation in melanoma successfully shrank tumors that spread to the brain in nine out of 10 patients in part of an international phase I clinical trial report.
